Is Mounjaro available as a pill or tablet?
Mounjaro is not available as a pill or tablet: Mounjaro (tirzepatide) from Eli Lilly only comes as a pen for injection once a week.
No tablet containing tirzepatide has been approved. In the SURMOUNT-1 study, the Mounjaro pen at the highest dose of 15 mg gave a weight loss of 20.9% over 72 weeks.[4]
Instead, Eli Lilly has developed a completely different pill with a different active substance. It is called Foundayo (orforglipron), is taken once a day and mimics the gut hormone GLP-1.[1]
When will Eli Lilly's weight loss pill Foundayo come to Denmark?
There is no date yet for when Eli Lilly's weight loss pill Foundayo will come to Denmark, because the pill first has to receive final approval in the EU.
Foundayo was approved in the USA on 1 April 2026. On 16 October 2026 the European Medicines Agency (EMA) recommended that Foundayo be approved in the EU for weight management and type 2 diabetes in adults. The next step is the European Commission's decision, and after that each country sets the price and reimbursement (tilskud).[5][1]
In the ATTAIN-1 study from 2025, with 3,127 adults over 72 weeks, Foundayo gave a weight loss of 7.5% with 6 mg, 8.4% with 12 mg and 11.2% with 36 mg, against 2.1% on placebo (an inactive dummy treatment). Eli Lilly itself reports 12.4% for those who stayed on the highest dose.[2][5]
What can you get today if you would rather have a pill?
If you would rather have a pill for weight loss today, a doctor can assess whether Wegovy as a daily tablet is right for you.
The Wegovy pill (semaglutide) has been on the Danish price list since 28 September 2026. In the OASIS 4 study, the highest dose of 25 mg gave a weight loss of 13.6% over 64 weeks against 2.2% on placebo. Figures from different studies cannot be compared directly.[3][6]
Today a doctor can prescribe Wegovy as a pen or pill and Mounjaro as a pen after an individual assessment. At Recepta the first doctor consultation is free.
| Medicine | Form | Status |
|---|---|---|
| Mounjaro (tirzepatide) | Pen, once a week | Can be prescribed in Denmark. Not available as a pill. |
| The Wegovy pill (semaglutide) | Tablet, once a day | On the Danish price list since 28 September 2026. |
| Foundayo (orforglipron) | Tablet, once a day | Approved in the USA. Recommended for approval in the EU on 16 October 2026. No date for Denmark. |
| Retatrutide | Injection, once a week | Still being tested. Not approved anywhere. |
Status as of November 2026.[1][6]
Read also: Wegovy or Mounjaro: which is better?
Questions and answers about Mounjaro as a pill
Is Foundayo the same as Mounjaro?
Is retatrutide a new pill from Eli Lilly?
What side effects does the weight loss pill Foundayo have?
Sources
- European Medicines Agency (EMA): New oral GLP-1 medicine for weight management and type 2 diabetes. News, 16 October 2026. ema.europa.eu
- Wharton S, Aronne LJ, Stefanski A, et al. Orforglipron, an oral small-molecule GLP-1 receptor agonist for obesity treatment (ATTAIN-1). New England Journal of Medicine 2025;393(18):1796-1806. doi.org
- Wharton S, Lingvay I, Bogdanski P, et al. Oral semaglutide at a dose of 25 mg in adults with overweight or obesity (OASIS 4). New England Journal of Medicine 2025;393(11):1077-1087. doi.org
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine 2022;387(3):205-216. doi.org
- Eli Lilly: Press release on the approval of Foundayo (orforglipron) in the USA, 1 April 2026.
- Recepta: Medication prices in Denmark (the Danish price list). recepta.dk